The study will investigate aspirin as a potential drug against covid-19


The study takes place in 176 hospitals across the UK and has so far recruited more than 16,000 patients.

Courtesy | Studies have already been conducted on the use of aspirin for the treatment of coronavirus

Aspirin, a drug commonly used to lower fever and relieve headaches, will now be evaluated as a possible treatment for COVID-19 in one of the largest UK surveys looking at a variety of possible treatments for the disease.

Patients infected with the new coronavirus have an increased risk of blood clots forming in blood vessels due to overactive platelets, which are small fragments of cells in the bloodstream that stop bleeding.

Since aspirin has blood-thinning properties, the scientists behind the Recovery project (an acronym for Randomized Evaluation of covid-19 Therapy) will include the drug in their studies, according to its website.

“There is a clear reason to believe that it could be useful and safe, inexpensive and widely available,” said Professor Peter Horby of the Nuffield Department of Medicine and co-principal investigator of the Recovery study.

“We are looking for covid-19 drugs that can be used immediately by anyone, anywhere in the world. We don’t know if aspirin is such a drug, but we’ll find out, ”Horby added.

The study is taking place in 176 hospitals across the UK and has so far recruited more than 16,000 patients.

At least 2,000 patients are expected to randomly receive 150 milligrams of aspirin per day along with their usual regimen. Data from these patients will be compared with at least 2,000 other patients receiving standard COVID-19 treatment alone, the website said.

The Recovery project is also investigating treatment with the antibiotic azithromycin, the drug Tocilizumab given by injection, and the Regeneron antibody cocktail, used to treat U.S. President Donald Trump’s symptoms of COVID-19.

Studies have already been done on the use of aspirin for the treatment of coronavirus. Researchers at the University of Maryland School of Medicine found that hospitalized COVID-19 patients who took low-dose daily aspirin to protect themselves from cardiovascular disease had a significantly lower risk of complications and death than those who did not take it. aspirin.

The study, published Oct. 21 in the scientific journal Anesthesia and Analgesia, analyzed medical records from 412 patients with Covid-19 treated at the University of Maryland Medical Center in Baltimore and three other hospitals along the east coast.

It found that those taking aspirin were less likely to be placed in the ICU or connected to a mechanical ventilator and more likely to survive the infection than hospitalized patients who were not taking aspirin.

Get the information instantly on your mobile. Join the Primicia Diary group on WhatsApp via the following link:

We are also on Telegram as @DiarioPrimicia, sign up here

Source link